New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - prednisone 1mg - tablet - 1 mg - active: prednisone 1mg excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose sodium starch glycolate - glucocorticoids are used to suppress the clinical manifestations of disease in a wide range of disorders such as: bronchial asthma, emphysema, pulmonary fibrosis, allergic skin reactions, blood disorders including auto-immune haemolytic anaemia and idiopathic thrombocytopenic purpura, selected collagen and rheumatic disorders (but rarely rheumatoid arthritis), connective tissue disorders such as arteritis and systemic lupus erythematosus, inflammatory bowel disease such as ulcerative colitis and crohn's disease, some hepatic disorders such as chronic active hepatitis, nephritic syndrome and other renal disorders, selected inflammatory ocular diseases, acute exacerbations of eczema, exfoliate dermatitis and pemphigus, and some neurological disorders such as infantile seizures (epilepsy) and sub-acute demyelinating polyneuropathy. miscellaneous uses include raised intracranial pressure, sarcoidosis, the neonatal respiratory distress syndrome, the gastric acid aspiration syndrome, acute rheumatic fever with carditis and occasionally hypercalcaemia. glucocorticoids may be used in conjunction with antineoplastic agents in regimens for the management of malignant disease such as leukaemia. they are also used to suppress the rejection phenomenon in tissue transplants.

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - prednisone 2.5mg - tablet - 2.5 mg - active: prednisone 2.5mg excipient: lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - glucocorticoids are used to suppress the clinical manifestations of disease in a wide range of disorders such as: bronchial asthma, emphysema, pulmonary fibrosis, allergic skin reactions, blood disorders including auto-immune haemolytic anaemia and idiopathic thrombocytopenic purpura, selected collagen and rheumatic disorders (but rarely rheumatoid arthritis), connective tissue disorders such as arteritis and systemic lupus erythematosus, inflammatory bowel disease such as ulcerative colitis and crohn's disease, some hepatic disorders such as chronic active hepatitis, nephritic syndrome and other renal disorders, selected inflammatory ocular diseases, acute exacerbations of eczema, exfoliate dermatitis and pemphigus, and some neurological disorders such as infantile seizures (epilepsy) and sub-acute demyelinating polyneuropathy. miscellaneous uses include raised intracranial pressure, sarcoidosis, the neonatal respiratory distress syndrome, the gastric acid aspiration syndrome, acute rheumatic fever with carditis and occasionally hypercalcaemia. glucocorticoids may be used in conjunction with antineoplastic agents in regimens for the management of malignant disease such as leukaemia. they are also used to suppress the rejection phenomenon in tissue transplants.

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - prednisone 20mg - tablet - 20 mg - active: prednisone 20mg excipient: colloidal silicon dioxide croscarmellose sodium erythrosine lactose monohydrate magnesium stearate microcrystalline cellulose - glucocorticoids are used to suppress the clinical manifestations of disease in a wide range of disorders such as: bronchial asthma, emphysema, pulmonary fibrosis, allergic skin reactions, blood disorders including auto-immune haemolytic anaemia and idiopathic thrombocytopenic purpura, selected collagen and rheumatic disorders (but rarely rheumatoid arthritis), connective tissue disorders such as arteritis and systemic lupus erythematosus, inflammatory bowel disease such as ulcerative colitis and crohn's disease, some hepatic disorders such as chronic active hepatitis, nephritic syndrome and other renal disorders, selected inflammatory ocular diseases, acute exacerbations of eczema, exfoliate dermatitis and pemphigus, and some neurological disorders such as infantile seizures (epilepsy) and sub-acute demyelinating polyneuropathy. miscellaneous uses include raised intracranial pressure, sarcoidosis, the neonatal respiratory distress syndrome, the gastric acid aspiration syndrome, acute rheumatic fever with carditis and occasionally hypercalcaemia. glucocorticoids may be used in conjunction with antineoplastic agents in regimens for the management of malignant disease such as leukaemia. they are also used to suppress the rejection phenomenon in tissue transplants.

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - prednisone 50mg;   - tablet - 50 mg - active: prednisone 50mg   excipient: magnesium stearate

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - prednisone 5mg - tablet - 5 mg - active: prednisone 5mg excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - glucocorticoids are used to suppress the clinical manifestations of disease in a wide range of disorders such as: bronchial asthma, emphysema, pulmonary fibrosis, allergic skin reactions, blood disorders including auto-immune haemolytic anaemia and idiopathic thrombocytopenic purpura, selected collagen and rheumatic disorders (but rarely rheumatoid arthritis), connective tissue disorders such as arteritis and systemic lupus erythematosus, inflammatory bowel disease such as ulcerative colitis and crohn's disease, some hepatic disorders such as chronic active hepatitis, nephritic syndrome and other renal disorders, selected inflammatory ocular diseases, acute exacerbations of eczema, exfoliate dermatitis and pemphigus, and some neurological disorders such as infantile seizures (epilepsy) and sub-acute demyelinating polyneuropathy. miscellaneous uses include raised intracranial pressure, sarcoidosis, the neonatal respiratory distress syndrome, the gastric acid aspiration syndrome, acute rheumatic fever with carditis and occasionally hypercalcaemia. glucocorticoids may be used in conjunction with antineoplastic agents in regimens for the management of malignant disease such as leukaemia. they are also used to suppress the rejection phenomenon in tissue transplants.

Ireland - English - HPRA (Health Products Regulatory Authority)

mundipharma pharmaceuticals limited - prednisone - modified-release tablets - 1 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

mundipharma pharmaceuticals limited - prednisone - modified-release tablets - 2 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

mundipharma pharmaceuticals limited - prednisone - modified-release tablets - 5 milligram